NICE guidance recommends regular monitoring of patients on GLP-1 receptor agonists, including assessment of gastrointestinal tolerability, weight changes, and glycaemic control
Understanding the risk factors can help you and your doctor make better decisions about your treatment
We Accept Medicare Root-Cause Care for the Whole Family | New Patients Welcome These peptides improve the sexual experience and optimize hormone levels
Lowers risk of heart failure and stroke The protective effects of GLP-1 medications translate into impressive reductions in serious cardiovascular events
GLP-1RA promotes weight loss, enhances insulin sensitivity, and exhibits anti-inflammatory and neuroprotective properties, potentially addressing key pathophysiological aspects of OSA
This evidence-based approach transforms breakfast from a challenge into an opportunity to amplify your treatment success